نتائج البحث

United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.

• Authors : Habib, Ali; Klink, Andrew; Muppidi, Srikanth

Subjects: Activities of daily living; C5; Chart review

• Source: Journal of Neurology. 271(9)

تفاصيل العنوان

Eculizumab as Additional Rescue Therapy in Myasthenic Crisis.

• Authors : Crescenzo, Francesco¹ (AUTHOR) ; Zanoni, Mattia¹ (AUTHOR); Ferigo, Laura¹ (AUTHOR)

• Source: Muscles (2813-0413). Mar2024, Vol. 3 Issue 1, p40-47. 8p.

تفاصيل العنوان

Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors

• Authors : Panse, Jens^1,2 (AUTHOR) ; Daguindau, Nicolas³ (AUTHOR); Okuyama, Sonia⁴ (AUTHOR)

Subjects: *PAROXYSMAL hemoglobinuria; *COMPLEMENT inhibition; *FATIGUE (Physiology)

• Source: PLoS ONE. 7/29/2024, Vol. 19 Issue 7, p1-20. 20p.

تفاصيل العنوان

Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.

• Authors : Tokuyasu, Daiki¹ (AUTHOR); Suzuki, Shigeaki¹ (AUTHOR) ; Uzawa, Akiyuki² (AUTHOR)

• Source: Annals of Clinical & Translational Neurology. May2024, Vol. 11 Issue 5, p1338-1346. 9p.

تفاصيل العنوان

Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (ACCESS 2)

• Source: A Randomized, Open-Label, Eculizumab and Ravulizumab Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients

تفاصيل العنوان

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China (Soliris)

• Authors : AstraZeneca

• Source: Prospective, Single-Arm, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Complement Inhibitor

تفاصيل العنوان

Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China (Soliris)

• Authors : AstraZeneca

• Source: Open-Label, Multicenter Study to Assess the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Complement Inhibitor Treatment

تفاصيل العنوان

Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvement.

• Authors : Lee, Benjamin; Arter, Zhaohui; Doh, Jean

Subjects: STEC‐HUS; Shiga‐toxin producing Escherichia coli; eculizumab

• Source: eJHaem. 5(3)

تفاصيل العنوان

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

• Source: A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients With Relapsing Neuromyelitis Optica Spectrum Disorder

تفاصيل العنوان

A Study Evaluating The Safety, Pharmacokinetics, and Efficacy Of Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors (COMMODORE 1)

• Authors : Chugai Pharmaceutical

• Source: A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Safety, Pharmacokinetics, Pharmacodynamic And Efficacy of Crovalimab Versus

تفاصيل العنوان